Dynavax Technologies
DVAX
#5116
Rank
S$2.35 B
Marketcap
S$20.05
Share price
0.00%
Change (1 day)
12.46%
Change (1 year)

P/S ratio for Dynavax Technologies (DVAX)

P/S ratio on July 2, 2026 (TTM) : 5.51

According to Dynavax Technologies 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.41. At the end of 2025 the company had a P/S ratio of 3.47.

P/S ratio history for Dynavax Technologies from 2004 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20253.47-43.7%
20246.16-20.77%
20237.78314.15%
20221.88-51.09%
20213.84-63.54%
202010.5-22.67%
201913.6-80.59%
201870.2-97.98%
2017> 100025045.31%
201613.8-95%
2015276418.98%
201453.216.11%
201345.8-14.64%
201253.6175.33%
201119.526.1%
201015.4708.02%
20091.91111.82%
20080.9025-93.74%
200714.4-80.83%
200675.21006.01%
20056.80-46.81%
200412.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.15-60.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
5.24-4.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
3.12-43.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5.31-3.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.71-14.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.72-14.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.33-57.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
1.33-75.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
2.24-59.24%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel